Imperva Initiated at Outperform and 3 Must-See Initiated Stocks

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on December 4th.

Cleveland Biolabs (NASDAQ:CBLI): Burrill Institutional Research initiated coverage of this company with a rating of Mkt Outperform and a price target of $4.

Imperva (NYSE:IMPV): Oppenheimer initiated coverage of this company with a rating of Outperform and a price target of $37.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Flowserve (NYSE:FLS): KeyBanc Capital Mkts initiated coverage of this company with a rating of Buy and a price target of $160.

NCI Building Systems (NYSE:NCS): FBR Capital initiated coverage of this company with a rating of Outperform and a price target of $17.

Investing Insights: Is It Still A Safe Bet To Buy Stock In Las Vegas Sands?

More Articles About:   , , , , ,  

More from The Cheat Sheet